6 hours Why Halozyme Therapeutics (HALO) Could Beat Earnings Estimates Again Zacks
Halozyme Therapeutics (HALO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.